Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy.

Hillegass JM, Blumen SR, Cheng K, MacPherson MB, Alexeeva V, Lathrop SA, Beuschel SL, Steinbacher JL, Butnor KJ, Ramos-NiƱo ME, Shukla A, James TA, Weiss DJ, Taatjes DJ, Pass HI, Carbone M, Landry CC, Mossman BT.

Int J Cancer. 2011 Jul 1;129(1):233-44. doi: 10.1002/ijc.25666. Epub 2010 Nov 3.

2.

Enhanced uptake of porous silica microparticles by bifunctional surface modification with a targeting antibody and a biocompatible polymer.

Cheng K, Blumen SR, MacPherson MB, Steinbacher JL, Mossman BT, Landry CC.

ACS Appl Mater Interfaces. 2010 Sep;2(9):2489-95. doi: 10.1021/am100530t.

3.

Knowledge and perceptions of quality systems among Vermont laboratorians.

Blumen SR, Naud PS, Palumbo MV, McIntosh B, Wilcke BW Jr.

Public Health Rep. 2010 May-Jun;125 Suppl 2:73-80.

4.

Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas.

Ramos-Nino ME, Blumen SR, Pass H, Mossman BT.

Mol Cancer. 2007 Dec 21;6:81.

5.

HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Pass H, Carbone M, Testa JR, Altomare DA, Mossman BT.

Am J Respir Cell Mol Biol. 2008 Feb;38(2):209-17. Epub 2007 Sep 13.

6.

Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells.

Blumen SR, Cheng K, Ramos-Nino ME, Taatjes DJ, Weiss DJ, Landry CC, Mossman BT.

Am J Respir Cell Mol Biol. 2007 Mar;36(3):333-42. Epub 2006 Oct 12.

Supplemental Content

Loading ...
Support Center